Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality fitness tests could replace traditional assessments for overweight individuals

NCT ID NCT07654439

Knowledge-focused Sponsor: Selcuk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether mixed reality (MR) versions of common mobility tests, like the Timed Up and Go test, are as accurate and reliable as the traditional versions for overweight and obese adults. About 119 participants will perform both MR and conventional tests using a Meta Quest 3 headset. The goal is to see if digital assessments can offer a safe, standardized, and potentially remote way to evaluate functional performance in this population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mixed reality-based functional mobility tests (Timed Up and Go, 4-Meter Walk, Five-Repetition Sit-to-Stand) delivered via Meta Quest 3 headset
What this could lead to
If successful, this could provide a standardized, digital way to assess mobility in overweight/obese individuals, potentially enabling remote monitoring.
What could go wrong
This is an early-stage validation study, not a treatment trial. The mixed reality tests may not match traditional results due to depth perception or movement differences, limiting clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 119 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 18-65 years with overweight or obesity (BMI ≥25 kg/m²) who are able to ambulate independently and are eligible to participate in conventional and mixed reality-based functional mobility and performance assessments.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body Mass Index (BMI) ≥ 25 kg/m² (overweight or obesity), * Ability to ambulate independently, * Aged between 18 and 65 years, * Willingness to participate voluntarily in the study and provide written informed consent. Exclusion Criteria: * Use of anti-obesity medication, * Pregnancy, * Latent autoimmune diabetes in adults (LADA), * Chronic kidney disease, * Active or severe infections, * Liver failure, * Recent major cardiovascular events, * Unstable angina, * Heart failure classified as New York Heart Association (NYHA) Class III-IV, * Respiratory failure, cardiac arrhythmias, neoplastic diseases, or neurological or musculoskeletal disorders that may limit the safe performance of the tests.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight and obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight and obesity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    RECRUITING

    Konya, Selcuklu, 42130, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.